Long non-coding RNA GRASLND links melanoma differentiation and interferon-gamma response

Front Mol Biosci. 2024 Sep 27:11:1471100. doi: 10.3389/fmolb.2024.1471100. eCollection 2024.

Abstract

Melanoma is a highly malignant tumor, that stands as the most lethal form of skin cancer and is characterized by notable phenotypic plasticity and intratumoral heterogeneity. Melanoma plasticity is involved in tumor growth, metastasis and therapy resistance. Long non-coding RNAs (lncRNAs) could influence plasticity due to their regulatory function. However, their role and mode of action are poorly studied. Here, we show a relevance of lncRNA GRASLND in melanoma differentiation and IFNγ signaling. GRASLND knockdown revealed switching of differentiated, melanocytic melanoma cells towards a dedifferentiated, slow-proliferating and highly-invasive cell state. Interestingly, GRASLND is overexpressed in differentiated melanomas and associated with poor prognosis. Accordingly, we found GRASLND expressed in immunological "cold" tumors and it negatively correlates with gene signatures of immune response activation. In line, silencing of GRASLND under IFNγ enhanced the expression of IFNγ-stimulated genes, including HLA-I antigen presentation, demonstrating suppressive activity of GRASLND on IFNγ signaling. Our findings demonstrate that in differentiated melanomas elevated expression of GRASLND interferes with anti-tumor effects of IFNγ, suggesting a role of GRASLND in tumor immune evasion.

Keywords: IFNγ response; differentiation; lncRNA; melanoma; phenotypic switch.

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. JI is currently CGCIII funded by Pfizer Inc. CGCIII is sponsored by Pfizer Inc., Merck KGaA, and AstraZeneca PLC. The sponsors had no role in the design, execution, interpretation or writing of the study. AP was supported by grants of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - SFB1430 - Project ID 424228829 and KFO337—Project ID 405344257 (PA 2376/1-2).